Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

Overview of attention for article published in Epidemiologic Reviews, January 1993

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy: 1 policy source
patent: 38 patents

video: 2 YouTube creators

Readers on

mendeley: 323 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 38 patents that reference this research output.

Concomitant administration of glucocorticoid receptor modulator relacorilant and…

Grant US-12589094-B2

United States of America

31 Mar 2026

Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin…

Grant US-12514849-B2

United States of America

06 Jan 2026

Treatments for amyotrophic lateral sclerosis using dazucorilant

Grant US-12433882-B2

United States of America

07 Oct 2025

Formulations of dazucorilant, a glucocorticoid receptor modulator

Grant US-12370188-B2

United States of America

29 Jul 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 34 additional patents.